{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:01:19Z","timestamp":1791000079374,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2307902"],"award-info":[{"award-number":["2023YFC2307902"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32200718"],"award-info":[{"award-number":["32200718"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82241075"],"award-info":[{"award-number":["82241075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["CIFMS 2022-I2M-1-021"],"award-info":[{"award-number":["CIFMS 2022-I2M-1-021"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["CIFMS 2021-I2M-1-038"],"award-info":[{"award-number":["CIFMS 2021-I2M-1-038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01193-y","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:11:14Z","timestamp":1751371874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques"],"prefix":"10.1038","volume":"10","author":[{"given":"Fengwen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1193_CR1","unstructured":"World Health Organization. 2022-24 Mpox (Monkeypox) Outbreak: Global Trends. Available from: https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/."},{"key":"1193_CR2","unstructured":"US FDA. FDA Mpox Response. Available from: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-issues\/fda-mpox-response."},{"key":"1193_CR3","doi-asserted-by":"publisher","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","volume":"79","author":"KJ Stittelaar","year":"2005","unstructured":"Stittelaar, K. J. et al. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. J. Virol. 79, 7845\u20137851 (2005).","journal-title":"J. Virol."},{"key":"1193_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/ije\/17.3.643","volume":"17","author":"PE Fine","year":"1988","unstructured":"Fine, P. E., Jezek, Z., Grab, B. & Dixon, H. The transmission potential of monkeypox virus in human populations. Int. J. Epidemiol. 17, 643\u2013650 (1988).","journal-title":"Int. J. Epidemiol."},{"key":"1193_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1126\/scitranslmed.adl4317","volume":"16","author":"C Jacob-Dolan","year":"2024","unstructured":"Jacob-Dolan, C. et al. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques. Sci. Transl. Med. 16, 27 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1193_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature02331","volume":"428","author":"PL Earl","year":"2004","unstructured":"Earl, P. L. et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428, 182\u2013185 (2004).","journal-title":"Nature"},{"key":"1193_CR7","doi-asserted-by":"publisher","first-page":"10889","DOI":"10.1073\/pnas.0804985105","volume":"105","author":"PL Earl","year":"2008","unstructured":"Earl, P. L. et al. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus. Proc. Natl. Acad. Sci. USA 105, 10889\u201310894 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1193_CR8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41591-023-02229-3","volume":"29","author":"Y Wolff Sagy","year":"2023","unstructured":"Wolff Sagy, Y. et al. Real-world effectiveness of a single dose of mpox vaccine in males. Nat. Med. 29, 748\u2013752 (2023).","journal-title":"Nat. Med."},{"key":"1193_CR9","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/v7041726","volume":"7","author":"L Sanchez-Sampedro","year":"2015","unstructured":"Sanchez-Sampedro, L. et al. The evolution of poxvirus vaccines. Viruses 7, 1726\u20131803 (2015).","journal-title":"Viruses"},{"key":"1193_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.46234\/ccdcw2024.025","volume":"6","author":"X Wang","year":"2024","unstructured":"Wang, X., Gu, Z., Sheng, S., Song, R. & Jin, R. The current state and progress of mpox vaccine research. China CDC Wkly. 6, 118\u2013125 (2024).","journal-title":"China CDC Wkly."},{"key":"1193_CR11","unstructured":"World Health Organization. Smallpox vaccines. Available from: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/smallpox-vaccines."},{"key":"1193_CR12","first-page":"1976","volume":"3","author":"M Kretzschmar","year":"2006","unstructured":"Kretzschmar, M., Wallinga, J., Teunis, P., Xing, S. Q. & Mikolajczyk, R. Frequency of adverse events after vaccination with different vaccinia strains (vol 3, art. no. e272, 2006). Plos Med. 3, 1976\u20131976 (2006).","journal-title":"Plos Med."},{"key":"1193_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","volume":"281","author":"JM Lane","year":"1969","unstructured":"Lane, J. M., Ruben, F. L., Neff, J. M. & Millar, J. D. Complications of smallpox vaccination, 1968. N. Engl. J. Med. 281, 1201\u20131208 (1969).","journal-title":"N. Engl. J. Med."},{"key":"1193_CR14","doi-asserted-by":"publisher","first-page":"002","DOI":"10.1016\/j.ijid.2004.09.002","volume":"8","author":"TP Monath","year":"2004","unstructured":"Monath, T. P. et al. ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)\u2013a second-generation smallpox vaccine for biological defense. Int. J. Infect. Dis. 8, 002 (2004).","journal-title":"Int. J. Infect. Dis."},{"key":"1193_CR15","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/nm916","volume":"9","author":"R Weltzin","year":"2003","unstructured":"Weltzin, R. et al. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat. Med 9, 1125\u20131130 (2003).","journal-title":"Nat. Med"},{"key":"1193_CR16","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/421266","volume":"38","author":"LH McCurdy","year":"2004","unstructured":"McCurdy, L. H., Larkin, B. D., Martin, J. E. & Graham, B. S. Modified vaccinia Ankara: potential as an alternative smallpox vaccine. Clin. Infect. Dis. 38, 1749\u20131753 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"1193_CR17","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","volume":"24","author":"J Kenner","year":"2006","unstructured":"Kenner, J., Cameron, F., Empig, C., Jobes, D. V. & Gurwith, M. LC16m8: an attenuated smallpox vaccine. Vaccine 24, 7009\u20137022 (2006).","journal-title":"Vaccine"},{"key":"1193_CR18","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1089\/aid.1992.8.1445","volume":"8","author":"J Tartaglia","year":"1992","unstructured":"Tartaglia, J. et al. Highly attenuated poxvirus vectors. AIDS Res. Hum. Retrovir. 8, 1445\u20131447 (1992).","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"1193_CR19","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1073\/pnas.0401165101","volume":"101","author":"LS Wyatt","year":"2004","unstructured":"Wyatt, L. S., Earl, P. L., Eller, L. A. & Moss, B. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc. Natl. Acad. Sci. USA 101, 4590\u20134595 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1193_CR20","doi-asserted-by":"publisher","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","volume":"25","author":"SE Frey","year":"2007","unstructured":"Frey, S. E. et al. Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge. Vaccine 25, 8562\u20138573 (2007).","journal-title":"Vaccine"},{"key":"1193_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","volume":"339","author":"CA Meseda","year":"2005","unstructured":"Meseda, C. A. et al. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model. Virology 339, 164\u2013175 (2005).","journal-title":"Virology"},{"key":"1193_CR22","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.1128\/JVI.03481-12","volume":"87","author":"GJ Hatch","year":"2013","unstructured":"Hatch, G. J. et al. Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques. J. Virol. 87, 7805\u20137815 (2013).","journal-title":"J. Virol."},{"key":"1193_CR23","unstructured":"Centers for Disease Control and Prevention. Interim Clinical Considerations for Use of JYNNEOS Vaccine for Mpox Prevention in the United States. Available from: https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/vaccines\/vaccine-considerations.html."},{"key":"1193_CR24","unstructured":"US FDA. Key Facts About Vaccines to Prevent Monkeypox Disease. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/key-facts-about-vaccines-prevent-monkeypox-disease."},{"key":"1193_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","volume":"72","author":"AF Dalton","year":"2023","unstructured":"Dalton, A. F. et al. Estimated effectiveness of JYNNEOS vaccine in preventing mpox: a multijurisdictional case-control study\u2014United States, August 19, 2022-March 31, 2023. Morb. Mortal. Wkly Rep. 72, 553\u2013558 (2023).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"1193_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/S0140-6736(24)01751-3","volume":"404","author":"P Adepoju","year":"2024","unstructured":"Adepoju, P. Mpox declared a public health emergency. Lancet 404, e1\u2013e2 (2024).","journal-title":"Lancet"},{"key":"1193_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/DDDT.S3687","volume":"4","author":"A Nalca","year":"2010","unstructured":"Nalca, A. & Zumbrun, E. E. ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile. Drug Des. Dev. Ther. 4, 71\u201379 (2010).","journal-title":"Drug Des. Dev. Ther."},{"key":"1193_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","volume":"84","author":"BL Jacobs","year":"2009","unstructured":"Jacobs, B. L. et al. Vaccinia virus vaccines: past, present and future. Antivir. Res 84, 1\u201313 (2009).","journal-title":"Antivir. Res"},{"key":"1193_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.virol.2005.02.014","volume":"335","author":"Q Fang","year":"2005","unstructured":"Fang, Q. et al. Host range, growth property, and virulence of the smallpox vaccine: Vaccinia virus Tian Tan strain. Virology 335, 242\u2013251 (2005).","journal-title":"Virology"},{"key":"1193_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/mt.2011.276","volume":"20","author":"KA Parato","year":"2012","unstructured":"Parato, K. A. et al. The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers. Mol. Ther. 20, 749\u2013758 (2012).","journal-title":"Mol. Ther."},{"key":"1193_CR31","first-page":"8751","volume":"61","author":"JA McCart","year":"2001","unstructured":"McCart, J. A. et al. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. Cancer Res. 61, 8751\u20138757 (2001).","journal-title":"Cancer Res."},{"key":"1193_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.cgt.7700075","volume":"7","author":"M Puhlmann","year":"2000","unstructured":"Puhlmann, M. et al. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant. Cancer Gene Ther. 7, 66\u201373 (2000).","journal-title":"Cancer Gene Ther."},{"key":"1193_CR33","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/317813a0","volume":"317","author":"RM Buller","year":"1985","unstructured":"Buller, R. M., Smith, G. L., Cremer, K., Notkins, A. L. & Moss, B. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 317, 813\u2013815 (1985).","journal-title":"Nature"},{"key":"1193_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/hum.2006.17.31","volume":"17","author":"AM Naik","year":"2006","unstructured":"Naik, A. M. et al. Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates. Hum. Gene Ther. 17, 31\u201345 (2006).","journal-title":"Hum. Gene Ther."},{"key":"1193_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.15252\/emmm.201607296","volume":"9","author":"KG Potts","year":"2017","unstructured":"Potts, K. G. et al. Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models. EMBO Mol. Med. 9, 638\u2013654 (2017).","journal-title":"EMBO Mol. Med."},{"key":"1193_CR36","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1186\/1472-6807-6-22","volume":"6","author":"K El Omari","year":"2006","unstructured":"El Omari, K., Solaroli, N., Karlsson, A., Balzarini, J. & Stammers, D. K. Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design. BMC Struct. Biol. 6, 1472\u20136807 (2006).","journal-title":"BMC Struct. Biol."},{"key":"1193_CR37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1128\/jvi.62.2.519-527.1988","volume":"62","author":"M Slabaugh","year":"1988","unstructured":"Slabaugh, M., Roseman, N., Davis, R. & Mathews, C. Vaccinia virus-encoded ribonucleotide reductase: sequence conservation of the gene for the small subunit and its amplification in hydroxyurea-resistant mutants. J. Virol. 62, 519\u2013527 (1988).","journal-title":"J. Virol."},{"key":"1193_CR38","first-page":"375","volume":"167","author":"A Mayr","year":"1978","unstructured":"Mayr, A., Stickl, H., M\u00fcller, H. K., Danner, K. & Singer, H. [The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author\u2019s transl)]. Zentralbl. Bakteriol. B 167, 375\u2013390 (1978).","journal-title":"Zentralbl. Bakteriol. B"},{"key":"1193_CR39","first-page":"104","volume":"144","author":"V Hochstein-Mintzel","year":"1972","unstructured":"Hochstein-Mintzel, V., Huber, H. C. & Stickl, H. Virulence and immunogenicity of a modified vaccinia virus (strain MVA) (author\u2019s transl)]. Z. Immunitatsforsch Exp. Klin. Immunol. 144, 104\u2013156 (1972).","journal-title":"Z. Immunitatsforsch Exp. Klin. Immunol."},{"key":"1193_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-019-0928-6","volume":"566","author":"JB Eaglesham","year":"2019","unstructured":"Eaglesham, J. B., Pan, Y., Kupper, T. S. & Kranzusch, P. J. Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling. Nature 566, 259\u2013263 (2019).","journal-title":"Nature"},{"key":"1193_CR41","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ez, B. et al. Viral cGAMP nuclease reveals the essential role of DNA sensing in protection against acute lethal virus infection. Sci. Adv. 6, https:\/\/doi.org\/10.1126\/sciadv.abb4565 (2020).","DOI":"10.1126\/sciadv.abb4565"},{"key":"1193_CR42","doi-asserted-by":"publisher","first-page":"1000984","DOI":"10.1371\/journal.ppat.1000984","volume":"6","author":"DB Gammon","year":"2010","unstructured":"Gammon, D. B. et al. Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis. PLoS Pathog. 6, 1000984 (2010).","journal-title":"PLoS Pathog."},{"key":"1193_CR43","doi-asserted-by":"publisher","unstructured":"Mei, S. et al. Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate. Front. Immunol. 13, https:\/\/doi.org\/10.3389\/fimmu.2022.911164 (2022).","DOI":"10.3389\/fimmu.2022.911164"},{"key":"1193_CR44","doi-asserted-by":"publisher","unstructured":"Sun, H. et al. A Nuclear Export Signal Is Required for cGAS to Sense Cytosolic DNA. Cell Rep. 34, https:\/\/doi.org\/10.1016\/J.Celrep.2020.108586 (2021).","DOI":"10.1016\/J.Celrep.2020.108586"},{"key":"1193_CR45","doi-asserted-by":"publisher","unstructured":"Fan, Z. L. et al. Development of a multiplex real-time PCR assay for the simultaneous detection of mpox virus and orthopoxvirus infections. J. Virol. Methods 328, https:\/\/doi.org\/10.1016\/j.jviromet.2024.114957 (2024).","DOI":"10.1016\/j.jviromet.2024.114957"},{"key":"1193_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jviromet.2010.07.012","volume":"169","author":"Y Li","year":"2010","unstructured":"Li, Y., Zhao, H., Wilkins, K., Hughes, C. & Damon, I. K. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA. J. Virol. Methods 169, 223\u2013227 (2010).","journal-title":"J. Virol. Methods"},{"key":"1193_CR47","unstructured":"Centers for Disease Control and Prevention. Test procedure: Monkeypox virus generic real-time PCR Test. Available from: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/pdf\/PCR-Diagnostic-Protocol-508.pdf."},{"key":"1193_CR48","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/infdis\/jiac414","volume":"227","author":"AJ Porzucek","year":"2023","unstructured":"Porzucek, A. J. et al. Development of an accessible and scalable quantitative polymerase chain reaction assay for monkeypox virus detection. J. Infect. Dis. 227, 1084\u20131087 (2023).","journal-title":"J. Infect. Dis."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01193-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:04:38Z","timestamp":1751414678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01193-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01193-y","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.G., F.X., Y.H. and S.M. are inventors on pending and issued patents on mpox vaccine. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationship that could be constructed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}